ESC Premium Access

Outcomes in patients with renal impairment and myocardial injury or infarction identified by high-sensitivity cardiac troponin testing: a secondary analysis of the High-STEACS trial

Topic: Renal Failure and Cardiovascular Disease

Congress Presentation

About the speaker

Doctor Peter Gallacher

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)
0 follower

8 more presentations in this session

Incidence, etiologies and predictors of 30-day readmission after percutaneous coronary intervention in end-stage renal disease patients; Analysis from national readmission database

Speaker: Professor A. Amanullah (Philadelphia, US)


Impact of Renal Dysfunction on Real-world Outcome of the ESC 0/1-hour Algorithm

Speaker: Professor R. Twerenbold (Hamburg, DE)


Left atrial volume index predicts improvement in renal function after catheter ablation of atrial fibrillation

Speaker: Doctor K. Usuda (Kanazawa, JP)


Early blood pressure reduction by intravenous vasodilators associates with acute kidney injury in patients with hypertensive acute decompensated heart failure

Speaker: Doctor Y. arao (Ogaki, JP)


Prognostic value of C-reactive protein / albumin ratio for cardiovascular morbidity and mortality in end-stage renal disease patients with incident haemodialysis therapy

Speaker: Assistant Professor H. Takahashi (Toyoake, JP)


Access the full session

Poster Session 2 - Kidney disease and the heart

Speakers: Doctor P. Gallacher, Professor A. Amanullah, Professor R. Twerenbold, Doctor K. Usuda, Doctor Y. arao...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb